Accession Number : ADA299786
Title : A Medical Research and Evaluation Facility (MREF) and Studies Supporting the Medical Chemical Defense Program: "Development of Procedures to Enhance Atropine Antisera Production in Rabbits.
Descriptive Note : Final rept. Jul 92-Jul 94,
Corporate Author : BATTELLE COLUMBUS DIV OH
Personal Author(s) : Olson, Carl T. ; Miller, Larry ; Bhullar, Balwant ; Benecke, Herman
PDF Url : ADA299786
Report Date : JUL 1994
Pagination or Media Count : 102
Abstract : The purpose of this study was to improve the production of rabbit anti-atropine antisera for future analytical studies. There were two phases to this project: evaluation of methods to enhance atropine antisera titers, and antisera production and characterization. Anti-atropine antisera were prepared using a high-density conjugate. The radioimmunoassay performance characteristics were similar for both the Battelle and Walter Reed Army Institute of Research antisera. However, a lower detection limit and a more dynamic response range were obtained with the Battelle antisera. Minor changes were made in the atropine radioimmunoassay to improve its reliability. There were approximately 250 mL of atropine antisera collected during this project, providing a useful antisera supply adequate for 250,000 tests.
Descriptors : *CHEMICAL WARFARE, *ANTIBODIES, *MEDICAL RESEARCH, *ATROPINE, DETECTION, DEFENSE SYSTEMS, PRODUCTION, DYNAMIC RESPONSE, RELIABILITY, LIMITATIONS, HIGH DENSITY, LOW LEVEL, IMMUNE SERUMS, SUPPLIES, MEDICAL SERVICES, DYNAMIC RANGE, PREVENTIVE MEDICINE, RADIOIMMUNOASSAY.
Subject Categories : Medicine and Medical Research
Chemical, Biological and Radiological Warfare
Distribution Statement : APPROVED FOR PUBLIC RELEASE